<p>Several HIV-1 neutralizing antibodies (e.g. 2F5, 4E10) have been shown to react with self-antigens, suggesting that effective humoral responses to HIV-1 may be constrained by the tolerization of HIV-reactive B cells that also recognize self-antigens. I have tracked the development of 2F5-like HIV-1 gp41 membrane proximal external region (MPER)-reactive B cells throughout ontogeny using B-cell tetramer reagents. In BL/6 mice, MPER-binding populations are lost during normal B-cell development and immunization with HIV-1 MPER antigen does not elicit robust humoral responses. I have identified Kynureninase as a self-antigen that is recognized by 2F5 antibody and, therefore, is a molecule that could mediate the developmental loss of B cells r...
The induction of a broadly neutralizing antibody (BNAb) response against HIV-1 would be a desirable ...
Unseparated peripheral blood mononuclear cells (PBMCs) obtained from drug-naïve African ...
Summary: Mucosal immune responses to HIV-1 involve the recognition of the viral envelope glycoprotei...
Self-reactivity may explain the rarity of HIV-1-specific broadly neutralising antibodies directed ag...
<p>Many human monoclonal antibodies that neutralize multiple clades of HIV-1 are polyreactive and bi...
Human immunodeficiency virus type-1 (HIV-1) is the etiologic agent of acquired immune deficiency syn...
The underlying mechanism responsible for the development of broadly neutralizing antibodies (bNAbs) ...
Broadly neutralizing antibodies (bNAbs) against HIV-1 have been increasingly isolated since 2009. Th...
Although there is no convincing evidence that HIV infects primary B cells, marked changes in B cell ...
Induction of broadly neutralising antibodies (bnAbs) capable of inhibiting infection with diverse va...
The maturation process of high-affinity antibodies is a result of intricate interactions between B c...
Multiple dysfunctions take place in the B cell compartment during HIV-1 infection, comprising deplet...
A central focus in the pursuit of an effective vaccine against HIV-1 is the induction of broadly neu...
<div><p>The induction of a broadly neutralizing antibody (BNAb) response against HIV-1 would be a de...
SummaryDevelopment of strategies for induction of HIV-1 broadly neutralizing antibodies (bnAbs) by v...
The induction of a broadly neutralizing antibody (BNAb) response against HIV-1 would be a desirable ...
Unseparated peripheral blood mononuclear cells (PBMCs) obtained from drug-naïve African ...
Summary: Mucosal immune responses to HIV-1 involve the recognition of the viral envelope glycoprotei...
Self-reactivity may explain the rarity of HIV-1-specific broadly neutralising antibodies directed ag...
<p>Many human monoclonal antibodies that neutralize multiple clades of HIV-1 are polyreactive and bi...
Human immunodeficiency virus type-1 (HIV-1) is the etiologic agent of acquired immune deficiency syn...
The underlying mechanism responsible for the development of broadly neutralizing antibodies (bNAbs) ...
Broadly neutralizing antibodies (bNAbs) against HIV-1 have been increasingly isolated since 2009. Th...
Although there is no convincing evidence that HIV infects primary B cells, marked changes in B cell ...
Induction of broadly neutralising antibodies (bnAbs) capable of inhibiting infection with diverse va...
The maturation process of high-affinity antibodies is a result of intricate interactions between B c...
Multiple dysfunctions take place in the B cell compartment during HIV-1 infection, comprising deplet...
A central focus in the pursuit of an effective vaccine against HIV-1 is the induction of broadly neu...
<div><p>The induction of a broadly neutralizing antibody (BNAb) response against HIV-1 would be a de...
SummaryDevelopment of strategies for induction of HIV-1 broadly neutralizing antibodies (bnAbs) by v...
The induction of a broadly neutralizing antibody (BNAb) response against HIV-1 would be a desirable ...
Unseparated peripheral blood mononuclear cells (PBMCs) obtained from drug-naïve African ...
Summary: Mucosal immune responses to HIV-1 involve the recognition of the viral envelope glycoprotei...